CytoMed Therapeutics Ltd (GDTC) — real insider trading activity disclosed to the SEC, tracked automatically as new Form 4 filings are reported. Most recent: Choo Chee Kong — 2 open-market purchases between 2026-07-14 and 2026-07-20, totaling $300,000.
Transactions disclosed by company insiders to the SEC on Form 4, most recent first.
| Insider | Role | Date | Shares | Value |
|---|---|---|---|---|
| Choo Chee Kong | Director | 2026-07-20 | 100,000 | $150,000 |
| Choo Chee Kong | Director | 2026-07-14 | 100,000 | $150,000 |
Data compiled from public SEC filings. This is informational reporting, not investment advice.
CytoMed Therapeutics Ltd (NASDAQ: GDTC) just posted its second insider purchase in under a week, and the pattern is starting to look like more than coincidence. On July 20, 2026, Choo Chee Kong, who serves as both a Director and a 10%+ owner of the company, bought 100,000 shares on the open market at $1.50 … Read more